Farewell to Broadway’s iconic ‘Phantom:’ Final shows sell out as some tickets go for up to $4,000
After more than three decades, Broadway’s longest-running musical, “The Phantom of the Opera,” is coming to an close on Sunday.
Justice Department to announce charges against more than 24 Mexican drug cartel members
The action is part of the Drug Enforcement Administration’s push to target the Sinaloa and Jalisco New Generation Cartel (CJNG) groups.
Credit card interest rates now top 20% on average — here are the 3 best ways to pay down debt
Americans owe more on credit cards than ever before. And they’re paying a higher price for it, as well.
Fort Lauderdale got 25 inches of rain in ‘unprecedented’ storm
The Florida city’s airport ceased flight activity for a second day after roads and runways were flooded in Wednesday’s storm.
Surprise oil output cuts from OPEC+ could hurt consumers and derail the economic recovery, IEA warns
The IEA said the energy alliance’s surprise production cut was likely to spell bad news for consumers at a time of heightened economic uncertainty.
Ron DeSantis signs Florida’s 6-week abortion ban into law
The governor had no fanfare around the bill-signing, sending out a news release late in the night.
Florida House passes six-week abortion ban backed by DeSantis
The six-week abortion ban bill now goes to Florida Gov. Ron DeSantis, who is expected to sign it into law.
Supreme Court allows $6 billion student loan debt settlement
The justices declined to intervene over a class-action settlement that could lead to the cancellation of more than 200,000 loans based on claims that colleges misled students.
Judge lets Trump lawyers question rape accuser E. Jean Carroll on LinkedIn founder funding
The writer E. Jean Carroll is suing former president Donald Trump for allegedly raping her in a New York department store in the 1990s, and later defaming her.
Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say
A complicated legal fight over abortion pill mifepristone could reduce innovation in the biopharma industry, companies and experts in law and economics said.
